LIVE: FDA Holds Roundtable on Strengthening Blood Manufacturing Supply Chain

Live News Network
1.4K followers
8 Video Views·Sep 29, 2026
The Food and Drug Administration holds a roundtable at 9 a.m. ET on Sept. 29 on strengthening the supply chain for the collection and manufacturing of whole blood, blood components, and source plasma. FDA officials and other stakeholders discuss supply chain challenges and potential solutions to help prevent shortages and ensure a safe and adequate U.S. blood supply.
Video Summary
AI GeneratedThis roundtable hosted by the FDA's OBRR focuses on transitioning the blood and plasma supply chain from a reactive to a preventative strategy. The discussion emphasizes mitigating risks associated with single-source manufacturers, geographic concentration, and regulatory fragmentation to ensure a stable, national security-level supply of critical medical materials.
